Levels of sGPVI (the soluble ectodomain of GPVI released from activated platelets by metalloproteolysis) in plasma pretransfusion fell within normal ranges observed in healthy donors [ 20 ], and showed a mean increase of 3.7 ng/ml from pretransfusion levels following cryoprecipitate transfusion ( p = 0.002) and a smaller increment following subsequent platelet transfusion, which did not reach statistical significance ( p = 0.06, Figure 3 ). sGPVI was subsequently measured in four apheresis cryoprecipitate units, showing a mean of 32.1 ng/ml.
← all excerpts
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia.
1
0.0600
0.0600